Integrity Financial’s iShares Biotechnology ETF IBB Stock Holding History

Integrity Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-289	Closed	-$36.6K	–	299
2025 Q2	$36.6K	Hold	289	–	–	0.02%	207
2025 Q1	$37K	Hold	289	–	–	0.02%	188
2024 Q4	$38.2K	Hold	289	–	–	0.02%	177
2024 Q3	$42.1K	Hold	289	–	–	0.02%	165
2024 Q2	$39.7K	Hold	289	–	–	0.02%	161
2024 Q1	$39.7K	Hold	289	–	–	0.03%	158
2023 Q4	$39.3K	Hold	289	–	–	0.03%	148
2023 Q3	$35.3K	Hold	289	–	–	0.03%	152
2023 Q2	$36.7K	Hold	289	–	–	0.03%	142
2023 Q1	$37.3K	Hold	289	–	–	0.03%	147
2022 Q4	$37.9K	Hold	289	–	–	0.04%	141
2022 Q3	$34K	Hold	289	–	–	0.04%	128
2022 Q2	$34K	Hold	289	–	–	0.03%	128
2022 Q1	$38K	Hold	289	–	–	0.03%	123
2021 Q4	$44K	Buy	+289	New	+$44.7K	0.03%	132

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Integrity Financial's IBB Position: Q3 2025 in Review

Integrity Financial sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 289 shares — an estimated $36.6K sold.

Integrity Financial first reported a position in IBB in Q4 2021 and held it in 15 quarters. The position peaked at $44K in Q4 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Integrity Financial reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Integrity Financial sold 289 iShares Biotechnology ETF shares in Q3 2025, an estimated $36.6K.
Integrity Financial first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 15 quarters.
Integrity Financial's iShares Biotechnology ETF position peaked at $44K in Q4 2021.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Integrity Financial's 13F filing for Q3 2025, filed 6 Nov 2025.